{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph.\n\nParagraph: Furthermore , we identified a glycine to alanine substitution in the collagenous domain that is apparently silent in the heterozygous carriers , in 11 .\n\nLet's think step by step."},
    {"role": "assistant", "content": "1. Heterozygous carriers: This term refers to individuals who carry one copy of a gene with a mutation, while the other copy is normal. In this context, it implies that the individuals do not exhibit any symptoms or diseases related to the mutation. Therefore, \"heterozygous carriers\" is not a disease entity, but rather a description of a genetic state.\n2. Collagenous domain: Collagen is a type of protein that provides structure and strength to various tissues in the body. Mutations in collagen genes can lead to various diseases, such as osteogenesis imperfecta, Ehlers-Danlos syndrome, and Marfan syndrome. However, in this paragraph, the collagenous domain itself is not identified as a disease, but rather a part of a protein where a specific mutation was identified.\n3. Glycine to alanine substitution: A substitution is a change in a single nucleotide or amino acid in a DNA or protein sequence. In this case, a glycine residue in the collagenous domain was replaced with an alanine residue. Whether this substitution is harmful or benign depends on the specific context and location in the protein sequence. Without further information, it is not possible to determine if this substitution is a disease entity.\n\nTherefore, based on the given paragraph, no clear disease entities were identified. The paragraph primarily discusses a genetic mutation in a collagenous domain and its apparent silence in heterozygous carriers."},
    {"role": "user", "content": "Please remove irrelevant entities and only keep the entities that clearly refer to Disease."},
    {"role": "assistant", "content": "Based on the given paragraph, there is no clear mention of any specific disease entity. The paragraph primarily discusses a genetic mutation in a collagenous domain and its apparent silence in heterozygous carriers. Therefore, no disease entities can be identified from the paragraph."},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| N/A |\n\nThere is no mention of any specific disease entity in the paragraph."}
  ]
}